You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dexamethasone Sodium Phosphate Preservative Free, and when can generic versions of Dexamethasone Sodium Phosphate Preservative Free launch?

Dexamethasone Sodium Phosphate Preservative Free is a drug marketed by Amneal, Fresenius Kabi Usa, and Somerset Theraps Llc. and is included in three NDAs.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dexamethasone Sodium Phosphate Preservative Free

A generic version of DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE was approved as dexamethasone sodium phosphate by HIKMA on September 7th, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE?
  • What are the global sales for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE?
  • What is Average Wholesale Price for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE?
Summary for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE
Drug patent expirations by year for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE
Recent Clinical Trials for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
King's College LondonN/A
City, University of LondonN/A
Guy's and St Thomas' NHS Foundation TrustN/A

See all DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE clinical trials

Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

US Patents and Regulatory Information for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 208690-001 Aug 22, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 040491-001 Apr 11, 2003 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset Theraps Llc DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 207442-001 Apr 19, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.